Home > News > New Nanotechnology Receives FDA Approval
December 12th, 2005
New Nanotechnology Receives FDA Approval
Abstract:
AcryMed Inc. today announced clearance from the Food And Drug Administration (FDA) for the first use of SilvaGard™, the company’s breakthrough silver nanotechnology that can render existing medical devices impervious to infection-causing bacteria. Unlike any other infection control technology available today, SilvaGard can be used to treat virtually any medical device and its use does not alter the device’s original properties.
Source:
prweb
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||